UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study

Frontiers in immunology, 2024-04, Vol.15, p.1354710

2024

Link zum Volltext

Verfügbarkeit prüfen

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy

Frontiers in immunology, 2023-08, Vol.14, p.1231734-1231734

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma

Frontiers in immunology, 2017-08, Vol.8, p.1024-1024

2017

Link zum Volltext

Verfügbarkeit prüfen

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report

BMC medical genomics, 2023-01, Vol.16 (1), p.1-9, Article 1

2023

Link zum Volltext

Verfügbarkeit prüfen

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells

Blood, 2004-08, Vol.104 (4), p.1183-1190

2004

Link zum Volltext

Verfügbarkeit prüfen

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice

Cancer biology & therapy, 2012-09, Vol.13 (11), p.1123-1140

2012

Link zum Volltext

Verfügbarkeit prüfen

Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment

Frontiers in immunology, 2015-02, Vol.6, p.46-46

2015

Link zum Volltext

Verfügbarkeit prüfen

Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report

Frontiers in immunology, 2015-03, Vol.6, p.144-144

2015

Link zum Volltext

Verfügbarkeit prüfen

Lessons from Cancer Immunoediting in Cutaneous Melanoma

Clinical & developmental immunology, 2012-01, Vol.2012, p.192719-14

2012

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell-based vaccine efficacy: aiming for hot spots

Frontiers in immunology, 2015-03, Vol.6, p.91-91

2015

Link zum Volltext

Verfügbarkeit prüfen

Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin

Breast cancer research and treatment, 2007-01, Vol.101 (2), p.161-174

2007

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition

International journal of oncology, 2020-06, Vol.56 (6), p.1429-1441

2020

Link zum Volltext

Verfügbarkeit prüfen

Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells

PloS one, 2012-07, Vol.7 (7), p.e40311-e40311

2012

Link zum Volltext

Verfügbarkeit prüfen

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

Frontiers in immunology, 2022-04, Vol.13, p.842555

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF

Frontiers in immunology, 2020-06, Vol.11, p.1147-1147

2020

Link zum Volltext

Verfügbarkeit prüfen

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients

Exploration of immunology, 2023-04, Vol.3 (2), p.82-103

2023

Link zum Volltext

Verfügbarkeit prüfen

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

Frontiers in immunology, 2018-05, Vol.9, p.955

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

Frontiers in immunology, 2017-05, Vol.8, p.625-625

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

Frontiers in immunology, 2019-09, Vol.10, p.2213

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: "Cancer Immunotherapy: Lights and Shadows"

Frontiers in immunology, 2015-07, Vol.6, p.350-350

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeted glycoproteomic identification of cancer cell glycosylation

Glycobiology (Oxford), 2009-08, Vol.19 (8), p.899-909

2009

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells

Innate immunity (London, England), 2009-04, Vol.15 (2), p.91-100

2009

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine

Cryobiology, 2013-10, Vol.67 (2), p.163-169

2013

Link zum Volltext

Verfügbarkeit prüfen

Melanoma e inmunidad

Acta bioquímica clínica latinoamericana, 2009-07, Vol.43 (3)

María Marcela Barrio

2009

Link zum Volltext

Verfügbarkeit prüfen

Quimiorresistencia del melanoma

Acta bioquímica clínica latinoamericana, 2009-07, Vol.43 (3)

María Marcela Barrio

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(61)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice

Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment

Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report

Lessons from Cancer Immunoediting in Cutaneous Melanoma

Dendritic cell-based vaccine efficacy: aiming for hot spots

Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition

Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

Editorial: "Cancer Immunotherapy: Lights and Shadows"

Targeted glycoproteomic identification of cancer cell glycosylation

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells

Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine

Melanoma e inmunidad

Quimiorresistencia del melanoma

Suchergebnisse filtern